Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lp(a)-PLAT: Platelet Reactivity in Elevated Lipoprotein(a) and Response to Antiplatelet Therapy
NCT07720934Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin and clopidogrel in cardiovascular disease (CVD) (2 arms). Primary endpoints: Change in collagen-induced platelet aggregation at Day 14 and Change in soluble platelet activation biomarkers at Day 14. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT07720934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07720934.